Obesity and airway responsiveness: Role of TNFR2

Pulmonary Pharmacology and Therapeutics

Volumn 26, Issue 4, 2013, Pages 444-454

  Williams, Alison S ^a   Chen, Lucas ^a   Kasahara, David I ^a   Si, Huiqing ^a   Wurmbrand, Allison P ^a   Shore, Stephanie A ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Airway responsiveness; Bronchoalveolar lavage; Endothelin; IL 17A; Inflammation; TNF ; TrkB

Indexed keywords

COMPLEMENT FACTOR D; ENDOTHELIN; INTERLEUKIN 17; INTERLEUKIN 7; METHACHOLINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; LUNG LAVAGE; LUNG MECHANICS; MICROARRAY ANALYSIS; MORPHOGENESIS; MOUSE; NONHUMAN; OBESITY; OSCILLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT ALLERGY;

EID: 84880512927     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2012.05.001     Document Type: Article

References (92)

1. Beuther D.A., Sutherland E.R. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med 2007, 175:661-666.
2. Ford E.S. The epidemiology of obesity and asthma. JAllergy Clin Immunol 2005, 115:897-909. quiz 10.
3. Litonjua A.A., Gold D.R. Asthma and obesity: common early-life influences in the inception of disease. JAllergy Clin Immunol 2008, 121:1075-1084. quiz 85-6.
4. Shore S.A., Johnston R.A. Obesity and asthma. Pharmacol Ther 2006, 110:83-102.
5. Maniscalco M., Zedda A., Faraone S., Cerbone M.R., Cristiano S., Giardiello C., et al. Weight loss and asthma control in severely obese asthmatic females. Respir Med 2008, 102:102-108.
6. Dixon A.E., Pratley R.E., Forgione P.M., Kaminsky D.A., Whittaker-Leclair L.A., Griffes L.A., et al. Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation. JAllergy Clin Immunol 2011, 128:508-515. e2.
7. Shore S.A. Obesity, airway hyperresponsiveness, and inflammation. JAppl Physiol 2009, 00749.2009.
8. Johnston R.A., Theman T.A., Shore S.A. Augmented responses to ozone in obese carboxypeptidase E-Deficient mice. Am J Physiol Regul Integr Comp Physiol 2006, 290:R126-R133.
9. Lu F.L., Johnston R.A., Flynt L., Theman T.A., Terry R.D., Schwartzman I.N., et al. Increased pulmonary responses to acute ozone exposure in obese db/db mice. Am J Physiol Lung Cell Mol Physiol 2006, 290:L856-L865.
10. Shore S.A., Rivera-Sanchez Y.M., Schwartzman I.N., Johnston R.A. Responses to ozone are increased in obese mice. JAppl Physiol 2003, 95:938-945.
11. Johnston R.A., Theman T.A., Lu F.L., Terry R.D., Williams E.S., Shore S.A. Diet-induced obesity causes innate airway hyperresponsiveness to methacholine and enhances ozone-induced pulmonary inflammation. JAppl Physiol 2008, 104:1727-1735.
12. Tilg H., Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006, 6:772-783.
13. Scherer P.E. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006, 55:1537-1545.
14. Pickup J.C., Mattock M.B., Chusney G.D., Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997, 40:1286-1292.
15. Vozarova B., Weyer C., Hanson K., Tataranni P.A., Bogardus C., Pratley R.E. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 2001, 9:414-417.
16. Bastard J.P., Maachi M., Van Nhieu J.T., Jardel C., Bruckert E., Grimaldi A., et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both invivo and invitro. JClin Endocrinol Metab 2002, 87:2084-2089.
17. Teramoto S., Yamamoto H., Ouchi Y. Increased C-reactive protein and increased plasma interleukin-6 may synergistically affect the progression of coronary atherosclerosis in obstructive sleep apnea syndrome. Circulation 2003, 107:E40. 0.
18. Johnston R.A., Zhu M., Hernandez C.B., Williams E.S., Shore S.A. Onset of obesity in carboxypeptidase E-deficient mice and effect on airway responsiveness and pulmonary responses to ozone. JAppl Physiol 2010, 108:1812-1819.
19. Uysal K.T., Wiesbrock S.M., Hotamisligil G.S. Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity. Endocrinology 1998, 139:4832-4838.
20. Uysal K.T., Wiesbrock S.M., Marino M.W., Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997, 389:610-614.
21. Park E.J., Lee J.H., Yu G.Y., He G., Ali S.R., Holzer R.G., et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 2010, 140:197-208.
22. Bouter B., Geary N., Langhans W., Asarian L. Diet-genotype interactions in the early development of obesity and insulin resistance in mice with a genetic deficiency in tumor necrosis factor-alpha. Metabolism 2010, 59:1065-1073.
23. Liang H., Yin B., Zhang H., Zhang S., Zeng Q., Wang J., et al. Blockade of tumor necrosis factor (TNF) receptor type 1-mediated TNF-alpha signaling protected Wistar rats from diet-induced obesity and insulin resistance. Endocrinology 2008, 149:2943-2951.
24. De Taeye B.M., Novitskaya T., McGuinness O.P., Gleaves L., Medda M., Covington J.W., et al. Macrophage TNF-alpha contributes to insulin resistance and hepatic steatosis in diet-induced obesity. Am J Physiol Endocrinol Metab 2007, 293:E713-E725.
25. Castro-Giner F., Kogevinas M., Imboden M., de Cid R., Jarvis D., Machler M., et al. Joint effect of obesity and TNFA variability on asthma: two international cohort studies. Eur Respir J 2009, 33:1003-1009.
26. Thomas P.S., Yates D.H., Barnes P.J. Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med 1995, 152:76-80.
27. Goukassian D.A., Qin G., Dolan C., Murayama T., Silver M., Curry C., et al. Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization. Circulation 2007, 115:752-762.
28. Kishore R., Tkebuchava T., Sasi S.P., Silver M., Gilbert H.Y., Yoon Y.S., et al. Tumor necrosis factor-alpha signaling via TNFR1/p55 is deleterious whereas TNFR2/p75 signaling is protective in adult infarct myocardium. Adv Exp Med Biol 2011, 691:433-448.
29. Sasi S.P., Yan X., Enderling H., Park D., Gilbert H.Y., Curry C., et al. Breaking the 'harmony' of TNF-alpha signaling for cancer treatment. Oncogene 2011.
30. Vandenabeele P., Declercq W., Beyaert R., Fiers W. Two tumour necrosis factor receptors: structure and function. Trends Cell Biol 1995, 5:392-399.
31. MacEwan D.J. TNF receptor subtype signalling: differences and cellular consequences. Cell Signal 2002, 14:477-492.
32. Naude P.J., den Boer J.A., Luiten P.G., Eisel U.L. Tumor necrosis factor receptor cross-talk. FEBS J 2011, 278:888-898.
33. Zhu M., Williams E.S., Shore S.A. Role of TNFR1 in the pulmonary phenotype of obese mice. Am J Respir Crit Care Med 2008, 176:A835.
34. Leibel R.L., Chung W.K., Chua S.C. The molecular genetics of rodent single gene obesities. JBiol Chem 1997, 272:31937-31940.
35. Coleman D.L., Eicher E.M. Fat (fat) and tubby (tub): two autosomal recessive mutations causing obesity syndromes in the mouse. JHered 1990, 81:424-427.
36. Salazar E., Knowles J.H. An analysis of pressure-volume characteristics of the lungs. JAppl Physiol 1964, 19:97-104.
37. Shore S.A., Williams E.S., Zhu M. No effect of metformin on the innate airway hyperresponsiveness and increased responses to ozone observed in obese mice. JAppl Physiol 2008, 105:1127-1133.
38. Rivera-Sanchez Y.M., Johnston R.A., Schwartzman I.N., Valone J., Silverman E.S., Fredberg J.J., et al. Differential effects of ozone on airway and tissue mechanics in obese mice. JAppl Physiol 2004, 96:2200-2206.
39. Hantos Z., Daroczy B., Suki B., Nagy S., Fredberg J.J. Input impedance and peripheral inhomogeneity of dog lungs. JAppl Physiol 1992, 72:168-178.
40. Shore S.A., Williams E.S., Chen L., Benedito L.A., Kasahara D.I., Zhu M. Impact of aging on pulmonary responses to acute ozone exposure in mice: role of TNFR1. Inhal Toxicol 2011, 23:878-888.
41. Ohashi K., Parker J.L., Ouchi N., Higuchi A., Vita J.A., Gokce N., et al. Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. JBiol Chem 2010, 285:6153-6160.
42. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
43. Irizarry R.A., Bolstad B.M., Collin F., Cope L.M., Hobbs B., Speed T.P. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003, 31:e15.
44. Li C., Hung Wong W. Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol 2001, 2. RESEARCH0032.
45. Li C., Wong W.H. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A 2001, 98:31-36.
46. Dennis G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003, 4:P3.
47. Katsuki A., Sumida Y., Murashima S., Murata K., Takarada Y., Ito K., et al. Serum levels of tumor necrosis Factor-α are increased in obese patients with noninsulin-dependent diabetes mellitus. JClin Endocrinol Metab 1998, 83:859-862.
48. Yamakawa T., Tanaka S.-I., Yamakawa Y., Kiuchi Y., Isoda F., Kawamoto S., et al. Augmented production of tumor necrosis Factor-α in obese mice. Clin Immunol Immunopathol 1995, 75:51-56.
49. Mei J., Liu Y., Dai N., Hoffmann C., Hudock K.M., Zhang P., et al. Cxcr2 and Cxcl5 regulate the IL-17/G-CSF axis and neutrophil homeostasis in mice. JClin Invest 2012, 122:974-986.
50. Richter M., Cloutier S., Sirois P. Endothelin, PAF and thromboxane A2 in allergic pulmonary hyperreactivity in mice. Prostaglandins Leukot Essent Fatty Acids 2007, 76:299-308.
51. Landgraf R.G., Jancar S. Endothelin A receptor antagonist modulates lymphocyte and eosinophil infiltration, hyperreactivity and mucus in murine asthma. Int Immunopharmacol 2008, 8:1748-1753.
52. Bennedich Kahn L., Gustafsson L.E., Olgart Hoglund C. Brain-derived neurotrophic factor enhances histamine-induced airway responses and changes levels of exhaled nitric oxide in guinea pigs invivo. Eur J Pharmacol 2008, 595:78-83.
53. Tighe R.M., Li Z., Potts E.N., Frush S., Liu N., Gunn M.D., et al. Ozone inhalation promotes CX3CR1-dependent maturation of resident lung macrophages that limit oxidative stress and inflammation. JImmunol 2011, 187:4800-4808.
54. Lajoie S., Lewkowich I.P., Suzuki Y., Clark J.R., Sproles A.A., Dienger K., et al. Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat Immunol 2010, 11:928-935.
55. Huang K., Rabold R., Abston E., Schofield B., Misra V., Galdzicka E., et al. Effects of leptin deficiency on postnatal lung development in mice. JAppl Physiol 2008, 105:249-259.
56. Rochester D.F., Enson Y. Current concepts in the pathogenesis of the obesity-hypoventilation syndrome. Mechanical and circulatory factors. Am J Med 1974, 57:402-420.
57. Ray C.S., Sue D.Y., Bray G., Hansen J.E., Wasserman K. Effects of obesity on respiratory function. Am Rev Respir Dis 1983, 128:501-506.
58. Johnston R.A., Zhu M., Rivera-Sanchez Y.M., Lu F.L., Theman T.A., Flynt L., et al. Allergic airway responses in obese mice. Am J Respir Crit Care Med 2007, 176:650-658.
59. Wagers S.S., Haverkamp H.C., Bates J.H., Norton R.J., Thompson-Figueroa J.A., Sullivan M.J., et al. Intrinsic and antigen-induced airway hyperresponsiveness are the result of diverse physiological mechanisms. JAppl Physiol 2007, 102:221-230.
60. Moon Y.S., Kim D.H., Song D.K. Serum tumor necrosis factor-alpha levels and components of the metabolic syndrome in obese adolescents. Metabolism 2004, 53:863-867.
61. Chen H., Tliba O., Van Besien C.R., Panettieri R.A., Amrani Y. TNF-[alpha] modulates murine tracheal rings responsiveness to G-protein-coupled receptor agonists and KCl. JAppl Physiol 2003, 95:864-872. discussion 3.
62. Amrani Y., Panettieri R.A., Frossard N., Bronner C. Activation of the TNF alpha-p55 receptor induces myocyte proliferation and modulates agonist-evoked calcium transients in cultured human tracheal smooth muscle cells. Am J Respir Cell Mol Biol 1996, 15:55-63.
63. Kung T.T., Luo B., Crawley Y., Garlisi C.G., Devito K., Minnicozzi M., et al. Effect of anti-mIL-9 antibody on the development of pulmonary inflammation and airway hyperresponsiveness in allergic mice. Am J Respir Cell Mol Biol 2001, 25:600-605.
64. Mould A.W., Ramsay A.J., Matthaei K.I., Young I.G., Rothenberg M.E., Foster P.S. The effect of IL-5 and eotaxin expression in the lung on eosinophil Trafficking and Degranulation and the induction of Bronchial hyperreactivity. JImmunol 2000, 164:2142-2150.
65. Sumarac-Dumanovic M., Stevanovic D., Ljubic A., Jorga J., Simic M., Stamenkovic-Pejkovic D., et al. Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women. Int J Obes 2008, 33:151-156.
66. Winer S., Paltser G., Chan Y., Tsui H., Engleman E., Winer D., et al. Obesity predisposes to Th17 bias. Eur J Immunol 2009, 39:2629-2635.
67. Pini M., Fantuzzi G. Enhanced production of IL-17A during zymosan-induced peritonitis in obese mice. JLeukoc Biol 2009, 87:51-58.
68. Zuniga L.A., Shen W.-J., Joyce-Shaikh B., Pyatnova E.A., Richards A.G., Thom C., et al. IL-17 Regulates adipogenesis, glucose homeostasis, and obesity. JImmunol 2010, 185:6947-6959.
69. He Y.W., Malek T.R. Interleukin-7 receptor alpha is essential for the development of gamma delta+ T cells, but not natural killer cells. JExp Med 1996, 184:289-293.
70. Inagaki-Ohara K., Nishimura H., Mitani A., Yoshikai Y. Interleukin-15 preferentially promotes the growth of intestinal intraepithelial lymphocytes bearing gamma delta T cell receptor in mice. Eur J Immunol 1997, 27:2885-2891.
71. Kudo M., Melton A.C., Chen C., Engler M.B., Huang K.E., Ren X., et al. IL-17A produced by [alpha][beta] T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction. Nat Med 2012, [advance online publication].
72. Willett W.C., Dietz W.H., Colditz G.A. Guidelines for healthy weight. NEngl J Med 1999, 341:427-434.
73. Burger C.D., Foreman A.J., Miller D.P., Safford R.E., McGoon M.D., Badesch D.B. Comparison of body habitus in patients with pulmonary arterial hypertension enrolled in the registry to evaluate early and long-term PAH disease management with normative values from the National Health and Nutrition Examination Survey. Mayo Clin Proc 2011, 86:105-112.
74. Kleemann R., Zadelaar S., Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res 2008, 79:360-376.
75. Nishina P.M., Lowe S., Wang J., Paigen B. Characterization of plasma lipids in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow. Metabolism 1994, 43:549-553.
76. Hakala K., Mustajoki P., Aittomaki J., Sovijarvi A.R. Effect of weight loss and body position on pulmonary function and gas exchange abnormalities in morbid obesity. Int J Obes Relat Metab Disord 1995, 19:343-346.
77. Rorvik S., Bo G. Lung volumes and arterial blood gases in obesity. Scand J Respir Dis Suppl 1976, 95:60-64.
78. Adiarto S., Emoto N., Iwasa N., Yokoyama M. Obesity-induced upregulation of myocardial endothelin-1 expression is mediated by leptin. Biochem Biophys Res Commun 2007, 353:623-627.
79. Silver A.E., Beske S.D., Christou D.D., Donato A.J., Moreau K.L., Eskurza I., et al. Overweight and obese humans demonstrate increased vascular endothelial NAD(P)H oxidase-p47(phox) expression and evidence of endothelial oxidative stress. Circulation 2007, 115:627-637.
80. Pontiroli A.E., Pizzocri P., Koprivec D., Vedani P., Marchi M., Arcelloni C., et al. Body weight and glucose metabolism have a different effect on circulating levels of ICAM-1, E-selectin, and endothelin-1 in humans. Eur J Endocrinol 2004, 150:195-200.
81. Ferri C., Bellini C., Desideri G., Baldoncini R., Properzi G., Santucci A., et al. Circulating endothelin-1 levels in obese patients with the metabolic syndrome. Exp Clin Endocrinol Diabetes 1997, 105(Suppl. 2):38-40.
82. Kahaleh M.B., Fan P.S. Effect of cytokines on the production of endothelin by endothelial cells. Clin Exp Rheumatol 1997, 15:163-167.
83. Lees D.M., Pallikaros Z., Corder R. The p55 tumor necrosis factor receptor (CD120a) induces endothelin-1 synthesis in endothelial and epithelial cells. Eur J Pharmacol 2000, 390:89-94.
84. Sibson N.R., Blamire A.M., Perry V.H., Gauldie J., Styles P., Anthony D.C. TNF-alpha reduces cerebral blood volume and disrupts tissue homeostasis via an endothelin- and TNFR2-dependent pathway. Brain 2002, 125:2446-2459.
85. Cardillo C., Campia U., Iantorno M., Panza J.A. Enhanced vascular activity of endogenous endothelin-1 in obese hypertensive patients. Hypertension 2004, 43:36-40.
86. Mather K.J., Mirzamohammadi B., Lteif A., Steinberg H.O., Baron A.D. Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes. Diabetes 2002, 51:3517-3523.
87. Ahlborg G., Shemyakin A., Bohm F., Gonon A., Pernow J. Dual endothelin receptor blockade acutely improves insulin sensitivity in obese patients with insulin resistance and coronary artery disease. Diabetes Care 2007, 30:591-596.
88. Weil B.R., Westby C.M., Van Guilder G.P., Greiner J.J., Stauffer B.L., DeSouza C.A. Enhanced endothelin-1 system activity with overweight and obesity. Am J Physiol Heart Circ Physiol 2011, 301:H689-H695.
89. Braun A., Lommatzsch M., Neuhaus-Steinmetz U., Quarcoo D., Glaab T., McGregor G.P., et al. Brain-derived neurotrophic factor (BDNF) contributes to neuronal dysfunction in a model of allergic airway inflammation. Br J Pharmacol 2004, 141:431-440.
90. Prakash Y.S., Thompson M.A., Pabelick C.M. Brain-derived neurotrophic factor in TNF-alpha modulation of Ca2+ in human airway smooth muscle. Am J Respir Cell Mol Biol 2009, 41:603-611.
91. Matera M.G., Calzetta L., Cazzola M. TNF-alpha inhibitors in asthma and COPD: we must not throw the baby out with the bath water. Pulm Pharmacol Ther 2010, 23:121-128.
92. Van Veen I.H., Ten Brinke A., Sterk P.J., Rabe K.F., Bel E.H. Airway inflammation in obese and nonobese patients with difficult-to-treat asthma. Allergy 2008, 63:570-574.